BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Investigator / Supervisor details

NameDr Steve Moore
Current InstitutionGlaxoSmithKline plc
Current DepartmentHarlow
Previous Institutions

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
00/A2/G/06503 Pleiotrophin signalling into oligodendrocytes by receptor protein tyrosine phosphatases Co-Supervisor 37,132 Studentships
terms and conditions of use (opens in new window)
export PDF file